CEO Emeritus, Inception Sciences

Peppi Prasit, Ph.D.


Peppi Prasit, Ph.D., is Chief Executive Officer Emeritus and Chair of the SAB of Inception Sciences. He has served as a key advisor for Versant since 2011.


Previously, Peppi was founder and CSO of Amira Pharmaceuticals, which was acquired by Bristol-Myers Squibb in a significant transaction. Peppi has more than 20 years of experience in pharmaceutical research and management serving in various positions with Merck Frosst Canada and then Merck San Diego. During this time, he played a pivotal role in the discovery of multiple marketed drugs and is widely recognized for his accomplishments as a drug hunter.

Peppi received his B.Sc. from UCL, London University, and his Ph.D. from Victoria University of Wellington in New Zealand and was a postdoctoral fellow at Princeton University.